Improving the Recognition of GBS and CIDP in the Hospital Setting: Live Program

Posted on

LIVE PROGRAM Designed for healthcare professionals. Earn AMA PRA Category 1 Credit™.

Date: Tuesday, September 25, 2018

Time: 12:00 PM – 1:00 PM EST

Join our experts for a one-hour, live webinar as they discuss how to manage patients with immune-mediated neuropathies such as GBS and CIDP.

Learning Objectives

  • Recognize signs and symptoms that may suggest a patient is presenting with an acute or chronic inflammatory neuropathy
  • Formulate a differential diagnosis for acute-onset CIDP from GBS and/or other similar neurological conditions
  • Recognize electrodiagnostic testing features that are characteristic of immune-mediated demyelinating neuropathies
  • Identify points of referral for patients with immune-mediated demyelinating neuropathies

Featured Speakers

Roy Freeman, MD, MB, ChB, Professor of Neurology
Harvard Medical School
Director, Center for Autonomic and Peripheral Nerve Disorders Beth Israel Deaconess Medical Center

Peter D. Donofrio, MD, Professor of Neurology
Chief, Division of Neuromuscular Disorders
Vice-Chair of Clinical Affairs
Vanderbilt University Medical Center

Mark D. Pearlmutter, MD, FACEP, Associate Professor of Emergency Medicine and Chair of Emergency Medicine
Steward Medical Group
Tufts University School of Medicine

Lisa Butler, Executive Director
GBS|CIDP Foundation International

Jon B. Schandler, Special Consultant
White Plains Hospital and Montefiore Health System


Watch top experts via streaming video, get the latest medical science, and earn AMA PRA Category 1 Credit™.

REGISTER HERE!